Proceeding contribution from Evan Harris (Liberal Democrat) in the House of Commons on Thursday, 14 June 2007. It occurred during Adjournment debate on Drug Classification.
Drug Classification
My hon. Friend is putting the case superbly; it really is a clear exposition of the dilemma. Judging from his work on the Committee, is he surprised that the ACMD has not yet got around to reviewing ecstasy? Does he think that the reason for that is that it knows it would undermine its credibility to do so, because the Government have given advance warning that they will not accept what the ACMD says? Does he agree that it is quite corrosive to the whole advisory system for the Government if committees do not believe that they can do work that they would otherwise do, because they will look stupid as the Government have pre-rejected their findings?
Secondary information
- Type
- Proceeding contribution
- Reference
- 461 c337WH
- Session
- 2006-07
- Chamber / Committee
- Westminster Hall
- Subjects
- Crime Drugs Health education Misuse Ecstasy Psilocybin
- Link
- View this Proceeding contribution on www.publications.parliament.uk
Librarians' tools
- Timestamp
- 2023-12-15 13:01:38 +0000
- URI
- http://data.parliament.uk/pimsdata/hansard/CONTRIBUTION_403197
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/pimsdata/hansard/CONTRIBUTION_403197
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/pimsdata/hansard/CONTRIBUTION_403197